ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RHONDA BEDELL MD

Internal Medicine

949

$19.2K

541
423 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$20
Average prescription price

Avg: $56

JENNIFER GILLIGAN M.D., PH.D.

Internal Medicine

947

$154K

156
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 26%

$162
Average prescription price

Avg: $56

CHRISTINE STOLTZ M.D.

Internal Medicine

940

$57.9K

107
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $56

ADEBUKOLA AKINTOYE MD

Internal Medicine

940

$41.9K

95
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

ANITHA NAGAPPAN M.D.

Internal Medicine

937

$31.2K

217
182 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$33
Average prescription price

Avg: $56

NKECHI MBAEZUE

Internal Medicine

919

$34.8K

84
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

CYNTHIA SHEPHERD MD

Internal Medicine

919

$277K

149
115 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 26%

$301
Average prescription price

Avg: $56

RASHMI KARANTH M.D.,

Internal Medicine

916

$44.3K

38
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

HARSHVADAN JOSHI MD

Internal Medicine

915

$110K

78
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$121
Average prescription price

Avg: $56

BRANDI DERRICK M.D.

Internal Medicine

914

$62.3K

130
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $56

EUGENE PAUL M.D.

Internal Medicine

896

$24.8K

162
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$28
Average prescription price

Avg: $56

RICKY MCCULLOUGH M.D.

Internal Medicine

894

$39.8K

45
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

JAMES THOMAS MD

Internal Medicine

878

$42.7K

70
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

JAMES SAMS MD

Internal Medicine

878

$56.5K

111
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $56

BHAGYA LAKSHMI PAPUDESU M.D.

Internal Medicine

873

$33.8K

118
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

MIKHAEL EL-CHAMI

Internal Medicine

871

$48.5K

153
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

CYNTHIA MCCALEB M.D.

Internal Medicine

869

$63.2K

41
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 26%

$73
Average prescription price

Avg: $56

WILLIAM SALAZAR MD

Internal Medicine

854

$31.8K

63
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

NEETA PATEL M.D.

Internal Medicine

841

$51.3K

70
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

ERNEST COKER MD

Internal Medicine

840

$43.9K

66
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

MARILYN DIGAMON-BELTRAN MD

Internal Medicine

837

$28.7K

62
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

TIMOTHY CONNELLY MD

Internal Medicine

822

$36.3K

120
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

RAMI REDDY BONAM M.D.

Internal Medicine

820

$27.6K

89
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

BECKY CAMPBELL MD

Internal Medicine

814

$41.4K

46
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

DAVID MATHIS MD

Internal Medicine

814

$41.4K

149
97 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank